From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Results: IPEL

Search articles by EPIC code
EPIC IPEL
views

Impellam Group – a recovery buy?

The latest results from staffing group Impellam (IPEL) included it emphasising “we are well placed to take advantage of a return to growth”. We have longer-term macroeconomic concerns, added to by the response to Covid-19, but do accept there is strong upcoming macroeconomic recovery potential. Many stocks in the recruitment sector have already responded, doubling and much more but here a current 294p to buy compares to a low of 220p and we see recovery potential back to 375p+. That makes the shares a recovery buy.

Page 1 of 4 (34 articles)
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments